Clinical Trial Update: Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC [Phase 2]

View source ↗

Summary

Overview of a Phase 2 trial comparing local consolidative radiation therapy added to a tyrosine kinase inhibitor versus TKI alone in driver-mutated oligometasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Oligometastatic Disease, Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING